Capital Ideas Podcast

Capital Group
undefined
Jan 2, 2025 • 22min

2025 Outlook

Martin Romo, Chairman and Chief Investment Officer at Capital Group, and Pramod Atluri, a fixed income portfolio manager, share insights on the economic landscape for 2025. They discuss inflation trends and interest rates as key factors influencing investments. The impact of the incoming Trump administration on global markets is a focal point, along with the opportunities in U.S. versus international equities, particularly in technology and energy. Expect higher yields as they advocate for balanced investment strategies in a recovering economy.
undefined
Dec 26, 2024 • 34min

Soaring with Capital Group Vice Chair Jody Jonsson

In this engaging discussion, Jody Jonsson, Vice Chair of Capital Group and an experienced pilot, shares her unique perspective on investing. She reveals how piloting has informed her approach to evaluating aerospace companies. Jody dives into her journey of investment strategy evolution, focusing on long-term successes in healthcare and insurance. Listeners will be captivated by her adventurous aerobatic experiences and the transformative power of mentorship in both aviation and finance.
undefined
7 snips
Dec 19, 2024 • 29min

Is 'The New Geography of Investing' still new?

Uncover the shifting world of investment as experts highlight how companies should be assessed based on their operational locations rather than their headquarters. Explore the potential resurgence of Japan amidst changing geopolitical dynamics and the charm of the U.S. market for foreign entities. Delve into the impact of digital disruption on industries, focusing on tech advancements and their implications on manufacturing. Finally, consider the importance of innovative management strategies and the role of historical economic perspectives in today's creative capitalism.
undefined
Dec 12, 2024 • 28min

AI spending spree: Where's the payoff?

Mark Casey, a portfolio manager dissecting key AI developments, and Jared Franz, an economist analyzing AI adoption rates, dive into the transformative world of artificial intelligence. They explore the potential for autonomous vehicles and the AI stack, while considering the looming threat of an 'AI winter.' The duo discusses the competitive landscape among tech giants and the economic implications of AI investments, balancing excitement with caution regarding market volatility and operational hurdles. A compelling mix of optimism and realism around AI's future awaits!
undefined
Dec 5, 2024 • 32min

Bond talk: When income is what you seek

Damien McCann, a fixed income portfolio manager at Capital Group with 24 years of experience, shares his unconventional investment strategies. He discusses transitioning from equity analysis to fixed income and the benefits of a multi-sector income strategy that aims for steady returns of about 6.5% to 7%. Damien reflects on navigating market risks and lessons from the global financial crisis, emphasizing the importance of a diversified portfolio. He also shares a personal story from his bowling days, showcasing the passion that fuels his professional journey.
undefined
Nov 28, 2024 • 22min

Travel revival: Investment opportunities by land, sea and air

Greg Miliotes, a seasoned Capital Group Equity Portfolio Manager with a rich 26-year background in industrial companies and global travel, offers insightful perspectives on investment trends. He discusses the resurgence of global travel as a booming opportunity post-COVID, particularly in air travel and cruises. Miliotes emphasizes the challenges facing Boeing while stressing the importance of AI in shaping future investments. Personal anecdotes reveal how his journey from family business to finance has influenced his adaptive investment strategies.
undefined
Nov 21, 2024 • 54min

U.S. Election Day key takeaways

Join political economist Matt Miller, ex-White House advisor, as he delves into the economic fallout from recent election results. Reagan Anderson, from Capital Group's government relations team, discusses potential shifts in policy and their implications. John Emerson, former U.S. ambassador to Germany, offers a global outlook on the new administration's role. Together, they unpack tax reforms, Federal Reserve decisions, and the evolving legislative landscape, emphasizing the need for steady investment strategies in turbulent political times.
undefined
Nov 14, 2024 • 32min

How bonds could shine as interest rates decline

What can investors expect from bonds now that interest rates are declining? Discover how bonds are back to their critical roles of providing income and diversification from equity markets. In a conversation with Mike Gitlin, Principal Investment Officer Pramod Atluri of The Bond Fund of America® discusses the Federal Reserve, his economic outlook and the mental models guiding his decisions. Pramod also gives us a glimpse into life with seven kids. If you're curious about where interest rates could land and how top minds at Capital Group navigate uncertainty, be sure to catch this valuable discussion. #CapGroupGlobal Take a look at the reading list Pramod mentions in this podcast: https://bit.ly/PDA_reading For full disclosures go to capitalgroup.com/global-disclosures For our latest insights, practice management ideas and more, subscribe to Capital Ideas at getcapitalideas.com. If you're based outside of the U.S., visit capitalgroup.com for Capital Group insights. Watch our latest podcast, Conversations with Mike Gitlin, on YouTube: https://bit.ly/CG-Gitlin-playlist This content is published by Capital Client Group, Inc. U.K. investors can view a glossary of technical terms here: https://bit.ly/49rdcFq To stay informed, follow us: LinkedIn: https://bit.ly/42uSYbm YouTube: https://bit.ly/4dFTE1B Follow Mike Gitlin: https://www.linkedin.com/in/mikegitlin/ About Capital Group Capital Group was established in 1931 in Los Angeles, California, with the mission to improve people's lives through successful investing. With our clients at the core of everything we do, we offer carefully researched products and services to help them achieve their financial goals. Learn more: capitalgroup.com Join us: capitalgroup.com/about-us/careers.html Copyright ©2024 Capital Group
undefined
Nov 7, 2024 • 25min

Confessions of a value investor

Can a value investor find opportunities in growth-oriented areas like artificial intelligence? Capital Group portfolio manager Charles Ellwein believes he can — by scouring the market for solid companies that aren't often featured on the front page of the Wall Street Journal. In this podcast, Ellwein shares his approach to identifying value in a market dominated by high-priced stocks. #CapGroupGlobal For full disclosures go to capitalgroup.com/global-disclosures For our latest insights, practice management ideas and more, subscribe to Capital Ideas at getcapitalideas.com. If you're based outside of the U.S., visit capitalgroup.com for Capital Group insights. Watch our latest podcast, Conversations with Mike Gitlin, on YouTube: https://bit.ly/CG-Gitlin-playlist This content is published by Capital Client Group, Inc. U.K. investors can view a glossary of technical terms here: https://bit.ly/49rdcFq To stay informed, follow us LinkedIn: https://bit.ly/42uSYbm YouTube: https://bit.ly/4dFTE1B Follow Mike Gitlin: https://www.linkedin.com/in/mikegitlin/ About Capital Group Capital Group was established in 1931 in Los Angeles, California, with the mission to improve people's lives through successful investing. With our clients at the core of everything we do, we offer carefully researched products and services to help them achieve their financial goals. Learn more: capitalgroup.com Join us: capitalgroup.com/about-us/careers.html Copyright ©2024 Capital Group
undefined
Oct 31, 2024 • 36min

Connecting the science and the business of drug innovation

Judith Finegold, a biopharmaceutical analyst at Capital Group and former cardiologist, shares her insights on drug innovation and investment. She discusses the years of research behind blockbuster drugs like Ozempic, the evolving landscape of drug pricing, and the shift towards advanced therapies. Topics include the promise of genetic sequencing in drug discovery, the impact of GLP-1 drugs in treating obesity, and the transformative role of antibody drug conjugates in cancer care. Finegold emphasizes the necessity of understanding both science and business for successful investing in biopharma.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app